Live Breaking News & Updates on Sinopharm covid vaccine

Stay informed with the latest breaking news from Sinopharm covid vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sinopharm covid vaccine and stay connected to the pulse of your community

South Asian Nations Turn To China, Russia For COVID-19 Vaccine Supplies

Sri Lanka began injecting pregnant women with a Chinese coronavirus vaccine on Wednesday and Nepal resumed inoculations with a China-made jab as India's neighbours turn to Beijing and Moscow for help with supplies.

Moscow , Moskva , Russia , Japan , Bangladesh , United-states , India , Colombo , Western , Sri-lanka , Dhaka , Nepal

Covid-19: Frequently asked questions about China's Sinopharm vaccine | India News

India News: NEW DELHI: China's Sinopharm is the first Chinese vaccine to be approved by the WHO.

China , Vietnam , Republic-of , Seychelles , Chinese , Sinovac-covid , China-national-pharmaceutical-group-co-ltd , World-health-organization-on , Strategic-advisory-group-of-experts , World-health-organization , Vero-cell , Advisory-group

The 'Cheena Abhagya' on the rise – The Island

The 'Cheena Abhagya' on the rise – The Island
island.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from island.lk Daily Mail and Mail on Sunday newspapers.

China , Ratnapura , Sabaragamuwa , Sri-lanka , Colombo , Western , Piliyandala , Palk-strait , Sri-lanka-general , Batticaloa , Eastern , Sri-lankan

sinopharm vaccine: WHO experts voice "very low confidence" in some Sinopharm COVID-19 vaccine data

Synopsis
"We are very confident that 2 doses of BBIBP-CorV are efficacious in preventing PCR confirmed COVID19 in adults (18-59 years)," the document said.
Agencies
Representative Image
WHO experts have voiced "very low confidence" in data provided by Chinese state-owned drugmaker Sinopharm on its COVID-19 vaccine regarding the risk of serious side-effects in some patients, but overall confidence in its ability to prevent the disease, a document seen by Reuters shows.
There was no immediate reply from the World Health Organization to a query about any concerns linked to the Sinopharm vaccine, BBIBP-CorV. In Beijing, Sinopharm was not immediately reachable for comment outside working hours.

China , Beijing , World-health-organization , Al-qahirah , Egypt , United-arab-emirates , Bahrain , Jordan , Chinese , Strategic-advisory-group-of-experts , Reuters

Sinopharm Covid vaccine safe for children, teenagers

Sinopharm Covid vaccine safe for children, teenagers
Reuters/Beijing
Photo: Reuters
Pfizer and Moderna have also included children as young as 12 years in their clinical trials.
A Covid-19 vaccine developed by China National Biotec Group (CNBG), a Sinopharm subsidiary, is safe in those aged between three and 17, based on clinical data obtained by the company, state media reported on Friday.
“It should be noted that for three to five-year-old children, because their immune system is still developing, they must be carefully and closely monitored during vaccination,” CNBG chairman Yang Xiaoming told Xinhua, without providing further details.
CNBG has two Covid-19 vaccines in Phase 3 clinical trials, both of which have been authorised for emergency use and are being given to limited priority groups at high risk of infection. A Sinovac Biotech Covid-19 candidate has also been authorised for emergency use.

China , Beijing , Sinovac-covid , Yang-xiaoming , Cansino-biologics , Pfizer , Institute-of-biological-products , China-national-biotec-group , Xinhua , Sinovac-biotech , Biological-products , Uae-news